Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic ...

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and ...

SystImmune, Inc. and Bristol Myers Squibb Announce First Global Phase I Results of Iza-bren ...

SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, and Bristol Myers Squibb (NYSE: BMY) today announced ...